Swiss chemotherapy trial for alveolar echinococcosis: Review of a 20- year clinical research project;Schweizerische studie fur chemotherapie der alveolaren echinokokkose - Ruckblick auf ein 20jahriges klinisches forschungsprojekt

Schweizerische Medizinische Wochenschrift

Volumn 129, Issue 8, 1999, Pages 323-332

  Ammann, R W ^a   Fleiner Hoffmann, A ^a   Eckert, J ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Alveolar echinococcosis; Chemotherapy; Long term results; Swiss trial

Indexed keywords

ALBENDAZOLE; BENZIMIDAZOLE DERIVATIVE; MEBENDAZOLE; ANTINEMATODAL AGENT;

ARTICLE; CLINICAL PROTOCOL; ECHINOCOCCOSIS; ECHINOCOCCUS MULTILOCULARIS; HUMAN; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; SWITZERLAND; TREATMENT OUTCOME; CLINICAL TRIAL; DISEASE TRANSMISSION; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; LIVER HYDATID CYST; LONG TERM CARE; MORTALITY; PROSPECTIVE STUDY; SURVIVAL RATE;

ALBENDAZOLE; ANTINEMATODAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ECHINOCOCCOSIS, HEPATIC; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MEBENDAZOLE; PROSPECTIVE STUDIES; SURVIVAL RATE; SWITZERLAND;

EID: 0033608317     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Eckert J. Prospects for treatment of the metacestode stage of echinococcosis. In: Thompson RCA, ed. The biology of echinococcus and hydatid disease. London: George Allan & Unwin; 1986; p. 250-84.
2. Witassek F, Burkhardt B, Eckert J, Bircher J. Chemotherapy of alveolar echinococcosis. Eur J Clin Pharmacol 1981;20: 427-33.
3. Luder PJ, Siffert B, Witassek F, Meister F, Bircher J. Treatment of hydatid disease with high oral doses of mebendazole. Eur J Clin Pharmacol 1986;31:443-8.
4. Müller E, Akovbiantz A, Ammann RW, Bircher J, Eckert J, Wissler K, et al. Treatment of human echinococcosis with mebendazole. Hepato-Gastronterol 1982;29:236-9.
5. Woodtli W, Bircher J, Witassek F, Eckert J, Wüthrich B, Ammann RW. Effect of plasma mebendazole concentrations in the treatment of human echinococcosis. Am J Trop Med Hyg 1985;34:754-60.
6. Gottstein B, Tschudi K, Eckert J, Ammann RW Em2-ELISA for the follow-up of alveolar echinococcosis after complete surgical resection of liver lesions,. Trans R Soc Trop Med Hyg 1989;83:389-93.
7. Ammann RW, Hirsbrunner R, Steiger U, Jacquier P, Eckert J. Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis. Am J Trop Med Hyg 1990;43:506-15.
8. Gottstein B, Mesarina B, Tanner I, Ammann RW, Lanier A, Parkinson A. Specific cellular and humoral immune responses in patients with different long-term courses of alveolar echinococcosis. Am J Trop Med Hyg 1991;45:734-42.
9. Otto R, Woodtli W, Amman RW. Sonographie versus Computer-Tomographie bei Lebermanifestationen der Echinokokkose. Dtsch Med Wochenschr 1982;107:1717-21.
10. Akovbiantz A, Ammann RW, Eckert J. Gibt es eine Chemotherapie der Echinokokkose des Menschen? Schweiz Med Wochcnschr 1978;108:1101-3.
11. Eckert J. Der «Kleine Fuchsbandwurm» (Echinococcus multilocularis) - eine persistierende Gefahr für den Menschen? Vierteljahresschrift der Naturforschenden Gesellschaft in Zürich 1998;143:57-66.
12. Schantz P. Van den Bosche H, Eckert J. Chemotherapy of larval echinococcosis in animals and humans. Report of a workshop. Z Parasitenkd 1982;67:5-26.
13. Ammann RW, Eckert J. Cestodes, echinococcosis. Gastroenterol Clin N Am 1996;25:655-89.
14. Gloor B. Echinokokkose beim Menschen in der Schweiz 1970-83. Inaug-Diss, Universität Zürich, 1988.
15. Eckert J, Jacquier P, Baumann D, RaeberPA. Echinokokkose des Menschen in der Schweiz 1984-1992. Schweiz Med Wochenschr 1995;125:1989-98.
16. Mesariua-Wicki B. Long-term course of alveolar echinococcosis in 70 patients treated by benzimidazole derivatives. Inaug Diss, Universität Zürich, 1991.
17. Ammann RW, Fleiner-Hoffmann A, Eckert J, SESG. Mortality and morbidity in 104 patients with alveolar echinococcosis in the Swiss chemotherapy trial (1476-1994). In: Uchino J, Sato N, eds. Alveolar echinococcosis, strategy for eradication of alveolar echinococcosis of the liver. Sapporo, Japan: Fuji Shoin; 1996; p. 283-92.
18. Fleiner-Hoffmann A, Ammann RW, Leu J, Ptammatter T, Hoffmann U. Sequelae of chronic vena cava obstruction in the hepatic segment. A study in patients with alveolar echinococcosis of the liver. Arch Intern Med. 1998;158:2503-8.
19. Suter M, Gilliet M. Liver transplantation in alveolar echinococcosis. Dig Surg 1997;14:229-34.
20. Robotti GC, Meister F, Schroeder R. Budd-Chiari-Syndrom bei Leberechinokokkose. Fortschr Röntgenstr 1985;142: 511-3.
21. Koch S, Bresson-Hadni S, Urusowsky S, Minello A, Heyd B, Bartholomot B, et al. Poursuite à longue terme de l'échinococcose alvéolaire après transplantation hépatique: résultats chez 13 malades, Gastroenterol Clin Biol 1997;21:A157.
22. WHO Informal Working Group on Echinococcosis. Guidelines for the treatment of cystic and alveolar echinococcosis in humans. Bull WHO 1996;74:231-42.
23. Deutsche Fassung, Chemotherapie Journal 1997;6:111-9.
24. Ammann RW. Improvement of liver resectional therapy by adjuvant chemotherapy in alveolar hydatid disease. Parasitol Res 1991;77:290-3.
25. Horton J. Albendazole: a review of the pharmacology, pharmacokinetics, clinical efficacy and safety in hydatid disease. In: Uchino J, Sato N, eds. Alveolar echinococcosis. Sapporo, Japan: Fuji Shoin; 1996; p. 261-82.
26. Eckert J, Jaquier P. Viability testing of Echinococcus multilocularis metacestodes from untreated and treated patients. Arch Hidatid 1991;30:863-7.
27. Ammann RW, Fleiner-Hoffmann A, Grimm F, Eckert J. Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosis. J Hepatol 1999;29:994-8.
28. Vuitton D, Bresson-Hadni S, Bartholomot B, Mantion G, Miguct JP. The natural history of alveolar echinococcosis before and during era of benzimidazoles. In: Uchino J, Sato N, eds. Alveolar echinococcosis. Sapporo, Japan: Fuji Shoin; 1996; p. 243-51.
29. Ammann RW. Alveolate Echinokokkose: Therapie mittels Chirurgie, Chemotherapie oder Kombination von beiden? Langenbecks Arch Chir 1992;377:65-7.
30. Davis A, Pawlowski ZS, Dixon H. Multicentre clinical trials of benzimidazole-carbonates in human echinococcosis. Bull WHO 1986:64:383-8.
31. Luder PJ, Robotti G. Meister FP, Bircher J. High oral doses of mebendazole interfere with growth of larval Echinococcus multiocularis lesions. J Hepatol 1985;1:369-77.
32. Ammann RW, llitsch N, Marincek B, Freiburghaus AU, SESG. Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis. Hepatol 1994; 19:735-42.
33. Wilson JF, Rausch RL, McMahon BJ. Schantz PM. Parasitocidal effect of chemotherapy in alveolar hydatid disease: review of experience with mebendazole and albendazole in Alaskan eskimos. Clin Infectious Dis 1992;15:234-49.
34. Kern P, Frosch P, Helbig M. Wechsler JG, Usadel S, Beckh K, et al. Diagnosis of Echinococcus multicularis infection by reverse-transcription PCR. Gastroenterology 1995;109: 596-600.
35. Gottstein B, Bettens F. Parkinson AJ, Wilson F. Immunological parameters associated with susceptibility or resistance to alveolar hydatid disease in Yupiks/Inupiats. Arctic Med Res 1996;55:14-9.
36. Eiermann TH, Bettens F, Tiberghien P, Schmitz K, Bresson-Hadni S, Vuitton D, Ammann RW, et al. HLA and alveolar echinococcosis. Tissue Antigens 1998;.52:124-9.
37. Sailer M, Soelder B, Allerberger F, Zakrun D, Feichtinger H, Gottstein B. Alveolar echinoccosis of the liver in a six-yearold girl with acquired immundeficiency syndrome. J Pediatr 1997;130:320-3.